John Despain, MD
Dermatology · Osage Beach, MONPI 1932196433
Payments from drug & device makers
Across 928 payments — averaging $351.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$205K
- Bristol Myers Squibb$50K
- Pfizer$37K
- Galderma Laboratories, L.p.$8K
- AbbVie$5K
- E.r. Squibb & Sons, L.L.C.$4K
- plus $16K from 30 others
Across 4 payments — averaging $3946.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Almirall LLC$16K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 215 | $204,859 |
| Bristol Myers Squibb | 51 | $50,302 |
| Pfizer | 41 | $37,444 |
| Galderma Laboratories, L.p. | 26 | $7,551 |
| AbbVie | 127 | $5,446 |
| E.r. Squibb & Sons, L.L.C. | 37 | $4,213 |
| Sun Pharmaceutical Industries Inc. | 43 | $3,128 |
| Regeneron Healthcare Solutions, Inc. | 36 | $2,850 |
| Genentech USA, Inc. | 25 | $2,302 |
| Almirall LLC | 20 | $1,267 |
| Johnson & Johnson | 55 | $1,266 |
| Lilly USA, LLC | 40 | $739 |
| Dermavant Sciences, Inc. | 29 | $709 |
| LEO Pharma Inc. | 28 | $660 |
| UCB, Inc. | 28 | $593 |
| Novartis | 25 | $448 |
| Sanofi | 20 | $377 |
| Janssen Scientific Affairs, LLC | 3 | $273 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $247 |
| Mayne Pharma Commercial LLC | 14 | $216 |
| Arcutis Biotherapeutics, Inc. | 9 | $201 |
| Biofrontera Inc. | 6 | $180 |
| Incyte Corporation | 8 | $159 |
| EPI Health, LLC | 6 | $106 |
| Kyowa Kirin, Inc. | 1 | $90 |
| Dermira, Inc. | 5 | $90 |
| DUSA Pharmaceuticals, Inc. | 1 | $87 |
| Novo Nordisk | 1 | $74 |
| Journey Medical Corporation | 3 | $54 |
| VYNE Pharmaceuticals Inc. | 3 | $47 |
| GRT US Holding, Inc. | 2 | $29 |
| Aclaris Therapeutics, Inc. | 1 | $23 |
| Pierre Fabre Pharmaceuticals, Inc. | 3 | $22 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Merck | 1 | $14 |
How this compares
$326,103 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Osage Beach
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
- Amy MusiekSaint Louis$577K
- Ann MartinSaint Louis$512K
- Jonathan CleaverKirksville$483K
- Mary GeorgeSaint Louis$400K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.